Literature DB >> 15464669

Cardiac troponin T elevation after coronary artery bypass grafting is associated with increased one-year mortality.

Sekar Kathiresan1, Stephen J Servoss, John B Newell, Dawn Trani, Thomas E MacGillivray, Kent Lewandrowski, Elizabeth Lee-Lewandrowski, James L Januzzi.   

Abstract

The results of the present study extend the value of assessing troponin T for the prediction of mortality rate 1 year after coronary artery bypass grafting; this study supports previous work that demonstrated the value of postoperative assessment of troponin T for the prediction of in-hospital adverse outcome after coronary artery bypass grafting.

Mesh：

Substances：

Year:  2004        PMID： 15464669     DOI： 10.1016/j.amjcard.2004.06.022

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


  15 in total

Review 1.  Cardioprotection during cardiac surgery.

Authors:  Derek J Hausenloy; Edney Boston-Griffiths; Derek M Yellon
Journal:  Cardiovasc Res       Date:  2012-03-22       Impact factor: 10.787

Review 2.  Diagnostic dilemma of perioperative myocardial infarction after coronary artery bypass grafting: A review.

Authors:  Viola Weidenmann; N Bryce Robinson; Lisa Q Rong; Irbaz Hameed; Ajita Naik; Mahmoud Morsi; Philippe Grieshaber; Andreas Böning; Leonard N Girardi; Mario Gaudino
Journal:  Int J Surg       Date:  2020-05-19       Impact factor: 6.071

3.  Effect of remote ischemic preconditioning on clinical outcomes in patients undergoing coronary artery bypass graft surgery (ERICCA): rationale and study design of a multi-centre randomized double-blinded controlled clinical trial.

Authors:  Derek J Hausenloy; Luciano Candilio; Chris Laing; Gudrun Kunst; John Pepper; Shyam Kolvekar; Richard Evans; Steve Robertson; Rosemary Knight; Cono Ariti; Tim Clayton; Derek M Yellon
Journal:  Clin Res Cardiol       Date:  2011-12-21       Impact factor: 5.460

4.  Effect of dexamethasone on postoperative cardiac troponin T production in pediatric cardiac surgery.

Authors:  Ignacio Malagon; Karin Hogenbirk; Johanes van Pelt; Mark G Hazekamp; James G Bovill
Journal:  Intensive Care Med       Date:  2005-09-16       Impact factor: 17.440

Review 5.  High sensitivity troponin measurement in critical care: Flattering to deceive or 'never means nothing'?

Authors:  Jonathan Hinton; Mark Mariathas; Michael Pw Grocott; Nick Curzen
Journal:  J Intensive Care Soc       Date:  2019-09-05

6.  Single-center experience with the combination of Cardioplexol™ cardioplegia and MiECC for isolated coronary artery bypass graft procedures.

Authors:  Hendrik Tevaeara Stahel; Silvio Barandun; Emilie Kaufmann; Brigitta Gahl; Lars Englberger; Hansjoerg Jenni; Alberto Weber; Thierry Aymard; Erich Gygax; Thierry Carrel
Journal:  J Thorac Dis       Date:  2019-06       Impact factor: 2.895

7.  Troponin testing after cardiac surgery.

Authors:  J L Januzzi
Journal:  HSR Proc Intensive Care Cardiovasc Anesth       Date:  2009

8.  Translating novel strategies for cardioprotection: the Hatter Workshop Recommendations.

Authors:  Derek J Hausenloy; Gary Baxter; Robert Bell; Hans Erik Bøtker; Sean M Davidson; James Downey; Gerd Heusch; Masafumi Kitakaze; Sandrine Lecour; Robert Mentzer; Mihaela M Mocanu; Michel Ovize; Rainer Schulz; Richard Shannon; Malcolm Walker; Gail Walkinshaw; Derek M Yellon
Journal:  Basic Res Cardiol       Date:  2010-09-24       Impact factor: 17.165

9.  A retrospective analysis of myocardial preservation techniques during coronary artery bypass graft surgery: are we protecting the heart?

Authors:  Luciano Candilio; Abdul Malik; Con Ariti; Sherbano A Khan; Matthew Barnard; Carmelo Di Salvo; David R Lawrence; Martin P Hayward; John A Yap; Amir M Sheikh; Christopher G A McGregor; Shyam K Kolvekar; Derek J Hausenloy; Derek M Yellon; Neil Roberts
Journal:  J Cardiothorac Surg       Date:  2014-12-31       Impact factor: 1.637

Review 10.  Ischaemic conditioning and reperfusion injury.

Authors:  Derek J Hausenloy; Derek M Yellon
Journal:  Nat Rev Cardiol       Date:  2016-02-04       Impact factor: 32.419
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.